Vitamin C

Generic Name
Vitamin C
Brand Names
Ascor, Citranatal B-calm Kit, Concept Ob, Ferralet 90, Hematogen, Infuvite, Infuvite Pediatric, Moviprep, Mvc-fluoride, Mvi Pediatric, Natafort, Plenvu, Pregvit, Vitafol-one
Drug Type
Small Molecule
Chemical Formula
C6H8O6
CAS Number
50-81-7
Unique Ingredient Identifier
PQ6CK8PD0R
Background

A six carbon compound related to glucose. It is found naturally in citrus fruits and many vegetables. Ascorbic acid is an essential nutrient in human diets, and necessary to maintain connective tissue and bone. Its biologically active form, vitamin C, functions as a reducing agent and coenzyme in several metabolic pathways. Vitamin C is considered an antioxi...

Indication

Used to treat vitamin C deficiency, scurvy, delayed wound and bone healing, urine acidification, and in general as an antioxidant. It has also been suggested to be an effective antiviral agent.

Associated Conditions
Common Cold, Deficiency, Vitamin A, Deficiency, Vitamin D, Fever, Flu caused by Influenza, Folate deficiency, Iron Deficiency (ID), Iron Deficiency Anemia (IDA), Oral bacterial infection, Scurvy, Vitamin C Deficiency, Vitamin Deficiency
Associated Therapies
Nutritional supplementation, Vitamin supplementation

High Dose Vitamin C in Cardiac Surgery Patients

First Posted Date
2016-05-04
Last Posted Date
2019-06-24
Lead Sponsor
Virginia Commonwealth University
Target Recruit Count
6
Registration Number
NCT02762331
Locations
🇺🇸

Virginia Commonwealth University Health System, Richmond, Virginia, United States

Lead Detoxifying Effects of Ascorbic Acid Among School Going Adolescents of Karachi- A Cluster Randomized Control Trial

Phase 2
Completed
Conditions
Interventions
First Posted Date
2016-04-20
Last Posted Date
2016-04-26
Lead Sponsor
Aga Khan University
Target Recruit Count
144
Registration Number
NCT02745873

Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia

Phase 3
Recruiting
Conditions
Interventions
Other: No systemic corticosteroid
Other: No antiviral agent for COVID-19
Other: No immune modulation for COVID-19
Drug: Standard course macrolide
Other: No antiviral agent for influenza
Drug: Local standard venous thromboprophylaxis
Other: No immunoglobulin
Other: No simvastatin
Other: No cysteamine
Other: No Immune Modulator for Influenza
Other: No vitamin C
Other: No antiplatelet
Procedure: Clinician-preferred mechanical ventilation strategy
Other: No renin-angiotensin system inhibitor
Other: No endothelial modulator
Drug: Ceftriaxone
Drug: Moxifloxacin or Levofloxacin
Drug: Extended course macrolide
Drug: Fixed-duration Hydrocortisone
Drug: Five-days oseltamivir
Drug: Lopinavir / Ritonavir
Biological: Convalescent plasma
Drug: Angiotensin converting enzyme inhibitor
Drug: Nirmatrelvir/ritonavir
Drug: Therapeutic dose anticoagulation
Procedure: Protocolised mechanical ventilation strategy
Drug: Interferon beta-1a
Drug: Vitamin C
Drug: Simvastatin
Drug: Aspirin
Drug: Eritoran
Drug: Cysteamine
Drug: Imatinib
Drug: Shock-dependent hydrocortisone
Drug: Ten-days oseltamivir
Drug: P2Y12 inhibitor
Drug: Angiotensin Receptor Blockers
Drug: Conventional low dose thromboprophylaxis
Biological: Delayed administration of convalescent plasma
Drug: Piperacillin-tazobactam
Drug: Hydroxychloroquine
Drug: Anakinra
Drug: Apremilast
Drug: Baricitinib
Drug: Remdesivir
Drug: Fixed-duration higher dose Hydrocortisone
Drug: Hydroxychloroquine + lopinavir/ritonavir
Drug: Intermediate dose thromboprophylaxis
Drug: Nirmatrelvir/ritonavir + remdesivir
Drug: ARB + DMX-200
Drug: Ceftaroline
Drug: Baloxavir Marboxil
Drug: Tocilizumab
Drug: Amoxicillin-clavulanate
Drug: Fixed-duration dexamethasone
Drug: Five-days oseltamivir + baloxavir marboxil
Drug: Continuation of therapeutic dose anticoagulation
Drug: Ivermectin
Drug: Sarilumab
Drug: Ten-days oseltamivir + baloxavir marboxil
First Posted Date
2016-04-13
Last Posted Date
2024-07-12
Lead Sponsor
UMC Utrecht
Target Recruit Count
20000
Registration Number
NCT02735707
Locations
🇨🇦

Toronto Western Hospital, Toronto, Ontario, Canada

🇺🇸

University of Illinois Health, Chicago, Illinois, United States

🇦🇺

Bankstown-Lidcombe Hospital, Bankstown, New South Wales, Australia

and more 405 locations

High Dose Intravenous Ascorbic Acid in Severe Sepsis

Phase 2
Terminated
Conditions
Interventions
First Posted Date
2016-04-12
Last Posted Date
2021-02-16
Lead Sponsor
Christiana Care Health Services
Target Recruit Count
24
Registration Number
NCT02734147
Locations
🇺🇸

Chrisitana Care Health System-Christiana Hospital, Newark, Delaware, United States

Preoperative Melatonin or Vitamin C Administration on Postoperative Analgesia

First Posted Date
2015-12-24
Last Posted Date
2021-08-09
Lead Sponsor
Cukurova University
Target Recruit Count
55
Registration Number
NCT02639741
Locations
🇹🇷

Hakkı Ünlügenç, Adana, Turkey

"Novo C Plus" Vitamin C Containing Dietary Supplement Bioavailability in Healthy Subjects

Phase 1
Completed
Conditions
Interventions
First Posted Date
2015-11-17
Last Posted Date
2015-11-17
Lead Sponsor
Semmelweis University
Target Recruit Count
32
Registration Number
NCT02606773
Locations
🇭🇺

Semmelweis University - 1st Departement of Internal Medicine, Budapest, Hungary

Exploratory Study To Assess the Efficacy and Safety of a Triple Combination for Acute Pain Treatment in Patients With Temporomandibular Joint Disorders (TMJD).

First Posted Date
2015-11-11
Last Posted Date
2017-01-19
Lead Sponsor
Spherium Biomed
Target Recruit Count
96
Registration Number
NCT02602483
Locations
🇪🇸

Hospital Universitario Rey Juan Carlos, Móstoles, Madrid, Spain

🇪🇸

Clinica Universitaria Odontològica de la Universitat Internacional de Catalunya, Sant Cugat del Valles, Barcelona, Spain

🇪🇸

Hospital Odontològic de la Universitat de Barcelona, Barcelona, Spain

and more 1 locations

Effect of Vitamin C on Postoperative Pain After Laparoscopic Cholecystectomy

First Posted Date
2015-09-17
Last Posted Date
2016-10-18
Lead Sponsor
Taeho Hong
Target Recruit Count
320
Registration Number
NCT02553551
Locations
🇰🇷

Department of HBP Surgery, Seoul St. Mary's hospital, Seoul, Seocho-gu, Banopo-dong, Korea, Republic of

Intravenous Ascorbic Acid in Women Receiving Adjuvant or Neo-Adjuvant Chemotherapy for Early Stage Breast Cancer

Phase 2
Withdrawn
Conditions
Interventions
First Posted Date
2015-08-13
Last Posted Date
2017-06-27
Lead Sponsor
Midwestern Regional Medical Center
Registration Number
NCT02521077
© Copyright 2024. All Rights Reserved by MedPath